MOSCOW (Sputnik) – Vaccines against COVID-19 by the Pfizer/BioNTech and AstraZeneca pharmaceutical companies were found effective against the Indian virus variant after…
The study, published late on Saturday, showed that „the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617.2 [Indian] variant 2 weeks after the second dose,“ while the effectiveness of the two-dose course of the AstraZeneca drug against the strain stood at 60%.
